Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Cystic Fibrosis (CF)Cystic Fibrosis Pulmonary Exacerbation

Trial Locations (1)

Manchester Adult Cystic Fibrosis Centre, Manchester University Hospitals NHS Foundation Trust, Manchester

All Listed Sponsors

lead

Alexander Horsley

OTHER

NCT06940531 - Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis | Biotech Hunter | Biotech Hunter